**Nevro Secures CE Mark Approval in Europe for HFX iQ™ Spinal Cord Stimulation System**
*October 2023*
Nevro Corp., a global leader in the field of neuromodulation, has recently announced that it has secured CE Mark approval in Europe for its innovative HFX iQ™ Spinal Cord Stimulation (SCS) System. This approval marks a significant milestone for the company and opens the door for the commercialization of the HFX iQ™ system across European markets. The HFX iQ™ system is the first and only artificial intelligence (AI)-powered SCS system designed to personalize and optimize pain relief for patients suffering from chronic pain.
### What is Spinal Cord Stimulation?
Spinal Cord Stimulation (SCS) is a well-established therapy used to manage chronic pain, particularly for patients who have not found relief through conventional treatments such as medications or surgery. The therapy involves implanting a small device that delivers electrical impulses to the spinal cord, which helps to modulate pain signals before they reach the brain. This can provide significant relief for patients suffering from conditions such as failed back surgery syndrome (FBSS), complex regional pain syndrome (CRPS), and other forms of neuropathic pain.
### The HFX iQ™ System: A Game-Changer in Pain Management
The HFX iQ™ system represents a major leap forward in the field of neuromodulation. Unlike traditional SCS systems, which require manual adjustments by healthcare providers, the HFX iQ™ system leverages artificial intelligence to automatically adjust stimulation settings based on real-time data from the patient. This personalized approach ensures that patients receive the most effective pain relief tailored to their unique needs.
The system is designed to learn from patient feedback and adapt over time, making it a dynamic and responsive solution for chronic pain management. The AI-driven platform continuously analyzes patient-reported outcomes and physiological data to optimize therapy settings, reducing the need for frequent in-office adjustments and improving overall patient satisfaction.
### Key Features of the HFX iQ™ System
1. **AI-Powered Personalization**: The HFX iQ™ system uses advanced algorithms to tailor therapy to each patient’s specific pain patterns and lifestyle. This personalized approach can lead to more effective pain relief and a better quality of life for patients.
2. **Real-Time Data Collection**: The system collects and analyzes data from the patient in real-time, allowing for continuous optimization of therapy settings. This reduces the need for manual adjustments and ensures that patients receive the most effective treatment at all times.
3. **Remote Programming**: The HFX iQ™ system allows healthcare providers to remotely monitor and adjust therapy settings, reducing the need for in-person visits. This is particularly beneficial for patients who may have difficulty traveling to appointments due to their chronic pain.
4. **Patient-Centric Design**: The system is designed with the patient in mind, offering a user-friendly interface and easy-to-use controls.